(Q52896373)

9 May 2018

title

Predicting quality of life from symptomatology in schizophrenia at exacerbation and stabilization. (English)

1 reference

9 May 2018

0 references

1 reference

Bow-Thomas CC

1

1 reference

9 May 2018

Velligan DI

series ordinal

2

1 reference

9 May 2018

Miller AL

series ordinal

3

1 reference

9 May 2018

Olsen J

series ordinal

4

1 reference

9 May 2018

language of work or name

English

0 references

publication date

1 May 1999

1 reference

9 May 2018

published in

Psychiatry Research

1 reference

9 May 2018

volume

86

1 reference

9 May 2018

issue

2

1 reference

9 May 2018

page(s)

131-142

1 reference

9 May 2018

Characterizing quality of life among patients with chronic mental illness: a critical examination of the self-report methodology

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900023-2

7 January 2021

National Institute of Mental Health longitudinal study of chronic schizophrenia. Prognosis and predictors of outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900023-2

7 January 2021

Treatment of negative symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900023-2

7 January 2021

Deficit and nondeficit forms of schizophrenia: the concept

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900023-2

7 January 2021

A comparison of instrument sensitivity to negative symptom change.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900023-2

7 January 2021

Natural history of schizophrenia subtypes. II. Positive and negative symptoms and long-term course

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900023-2

7 January 2021

The Quality of Life Scale: an instrument for rating the schizophrenic deficit syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900023-2

7 January 2021

Assessment of Enduring Deficit and Negative Symptom Subtypes in Schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900023-2

7 January 2021

Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: results of an international collaborative trial

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900023-2

7 January 2021

Quality of life measurement in schizophrenia: reconciling the quest for subjectivity with the question of reliability.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900023-2

7 January 2021

10.1016/S0165-1781(99)00023-2

Identifiers

DOI

1 reference

9 May 2018

1 reference

9 May 2018